Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBP-0276 in Active Psoriatic Arthritis
NCT07706530Phase 2Not yet recruiting
- Sponsor
- Clarent Biopharma Inc
- Start
- Jul 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 2 trial of CBP-0276 in psoriatic arthritis (PsA), sponsored by Clarent Biopharma Inc. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
CBP-0276
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT07706530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07706530.